Showing results (191-200 of 314) with videos related to

Sort By:
Pageof 32
European Journal of Nuclear Medicine and Molecular Imaging|March 7, 2020
Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617Justin Ferdinandus, John Violet, Shahneen Sandhu, et al.
Therapeutic Advances in Medical Oncology|June 16, 2023
Safety of Lutetium-177 prostate-specific membrane antigen-617 (PSMA-617) radioligand therapy in the setting of severe renal impairment: a case report and literature reviewDuncan E K Sutherland, Raghava Kashyap, Price Jackson, et al.
European Urology Focus|May 3, 2022
Gender Disparities Among Editorial Boards of International Urology JournalsMadeleine L Burg, Tamir Sholklapper, Priya Kohli, et al.
Pathology|January 15, 2011
Prostate tumour volume is an independent predictor of early biochemical recurrence in a high risk radical prostatectomy subgroupMatthew K H Hong, Benjamin Namdarian, Niall M Corcoran, et al.
World Journal of Urology|July 17, 2026
Neoadjuvant therapies for clear cell renal cell carcinoma: review of current evidence and future applicationsThomas McMaster, Niall McVeigh, David C Chen, et al.
European Urology|January 7, 2015
Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomyGiacomo Novara, James W F Catto, Timothy Wilson, et al.
BJU International|February 12, 2017
Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trialShankar Siva, Daniel Pham, Tomas Kron, et al.
Pageof 32